JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 2 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.45B |
| 3 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.34B |
| 4 |
EA
Electronic Arts
EA
|
+$903M |
| 5 |
Automatic Data Processing
ADP
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.63B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.06B |
| 3 |
Meta Platforms (Facebook)
META
|
+$942M |
| 4 |
Nike
NKE
|
+$779M |
| 5 |
Union Pacific
UNP
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.97% |
| 2 | Technology | 12.33% |
| 3 | Healthcare | 10.23% |
| 4 | Consumer Discretionary | 8.25% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RC
3751
Ready Capital
RC
$294M
| $998K | ﹤0.01% |
59,895
-553
| -0.9% | -$9.24K |
|
3752
BlackRock TCP Capital
TCPC
$353M
| $996K | ﹤0.01% |
69,987
+42,763
| +157% | +$626K |
|
3753
Ultragenyx Pharmaceutical
RARE
$2.6B
| $995K | ﹤0.01% |
13,037
-3,688
| -22% | -$300K |
|
3754
Dr. Reddy's Laboratories
RDY
$10.3B
| $992K | ﹤0.01% |
143,375
-570,070
| -80% | -$3.81M |
|
3755
AZZ Inc
AZZ
$4.52B
| $991K | ﹤0.01% |
19,623
+12,409
| +172% | +$662K |
|
3756
Riverview Bancorp
RVSB
$107M
| $990K | ﹤0.01% |
112,074
+36,553
| +48% | +$335K |
|
|
XCRA
3757
DELISTED
Xcerra Corporation
XCRA
| $989K | ﹤0.01% |
69,261
-13,725
| -17% | -$195K |
|
3758
Essent Group
ESNT
$6.23B
| $985K | ﹤0.01% |
22,251
+2,742
| +14% | +$112K |
|
3759
HealthStream
HSTM
$849M
| $985K | ﹤0.01% |
31,741
-36,334
| -53% | -$1.09M |
|
3760
State Street SPDR NYSE Technology ETF
XNTK
$2.27B
| $985K | ﹤0.01% |
10,426
+1,247
| +14% | +$117K |
|
3761
LivePerson
LPSN
$35.9M
| $984K | ﹤0.01% |
2,526
-5,590
| -69% | -$2.06M |
|
|
PRMW
3762
DELISTED
Primo Water Corporation
PRMW
| $982K | ﹤0.01% |
60,815
-2,564
| -4% | -$40.6K |
|
3763
Banc of California
BANC
$3.11B
| $980K | ﹤0.01% |
51,858
-32,414
| -38% | -$638K |
|
3764
CALL
Theravance Biopharma
TBPH
$878M
| $980K | ﹤0.01% |
+30,000
| New | +$818K |
|
|
3765
PUT
Theravance Biopharma
TBPH
$878M
| $980K | ﹤0.01% |
+30,000
| New | +$818K |
|
3766
Arbutus Biopharma
ABUS
$906M
| $979K | ﹤0.01% |
103,628
-113,873
| -52% | -$1.13M |
|
3767
LGI Homes
LGIH
$1.37B
| $977K | ﹤0.01% |
20,598
-622
| -3% | -$34.2K |
|
|
BCS.PRD.CL
3768
DELISTED
Barclays Bank Plc
BCS.PRD.CL
| $977K | ﹤0.01% |
37,536
-8,000
| -18% | -$211K |
|
3769
iShares California Muni Bond ETF
CMF
$4.63B
| $975K | ﹤0.01% |
16,817
+5,966
| +55% | +$348K |
|
3770
Icahn Enterprises
IEP
$5.33B
| $973K | ﹤0.01% |
13,763
+437
| +3% | +$32.4K |
|
|
LITS
3771
Lite Strategy Inc
LITS
$30.5M
| $973K | ﹤0.01% |
11,285
-7,056
| -38% | -$577K |
|
|
BECN
3772
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $973K | ﹤0.01% |
26,880
-110,167
| -80% | -$4.37M |
|
|
ANSS
3773
PUT
DELISTED
Ansys
ANSS
| $971K | ﹤0.01% |
+5,200
| New | +$931K |
|
|
VSTO
3774
DELISTED
Vista Outdoor Inc.
VSTO
| $971K | ﹤0.01% |
54,260
-186,452
| -77% | -$3.2M |
|
3775
Northrim BanCorp
NRIM
$601M
| $969K | ﹤0.01% |
93,328
+87,816
| +1,593% | +$927K |
|
Similar funds
JP Morgan Chase's Q3 2018 Portfolio in Review
As of Q3 2018, JP Morgan Chase held 6,019 positions worth $522B, up 7.4% from $486B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q3 2018 filing shows 449 new, 2,597 increased, 2,100 reduced and 313 closed positions. Its largest new stake was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B. The largest sale was Broadcom, an estimated $1.63B.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q3 2018 buy was JPMorgan BetaBuilders Canada ETF: 29,437,708 shares worth $1.45B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Japan ETF in Q3 2018, an estimated $1.83B increase.
- JP Morgan Chase's biggest Q3 2018 reduction was Broadcom, cutting an estimated $1.63B.
- JP Morgan Chase fully exited Cavium, Inc. in Q3 2018, selling an estimated $316M.
- JP Morgan Chase's ten largest holdings make up 18% of its $522B portfolio in Q3 2018.
- JP Morgan Chase opened 449 new positions and closed 313 in Q3 2018.
- JP Morgan Chase's portfolio value rose 7.4% quarter-over-quarter to $522B.
Based on JP Morgan Chase's 13F filing for Q3 2018, filed 7 Nov 2018.